Therefore, on the basis of clinical experience and current evidence, the Eastern and Southern Europe Diabetes and Obesity Expert Group recommends a personalized, polymodal approach (comprising GLP-1 RAs) tailored to individual patient's disease phenotype to optimize diabetes and obesity therapy. We ...
Basic patient information is provided in the Supplementary Information: Table S6. Animals All animal experiments conducted in this study were performed in compliance with the ARRIVE guidelines and followed the “Guide for the Care and Use of Laboratory Animals (the Guide)” published by the National...
“This tool provides real-time information on how lifestyle choices such as food, activity, medication and stress can impact a patient’s body. We both benefit from this data, and it makes it easier for a patient to stay engaged with these changes in the short- and long-term.” As a ...
Still, the rise in risk for stomach and/or bowels containing food or stool is troubling, the researchers said, since it brings "significant risks for missed lesions, patient dissatisfaction and procedure cancellation, with wasted resources." According to the researchers, the findings suggest the nee...
The dataset used in this study was extensive, encompassing various aspects of patient information including demographic details, diagnoses (according to International Classification of Diseases, Tenth Revision, Clinical Modification [ICD-10-CM] codes), procedures (classified according to the International ...
processing that information that health systems are generating. And of course, generative AI is generating a lot of excitement, and a lot of orgs are looking toward how those GenAI tools can be used for clinical documentation, like they already have been. And also to things like patient-f...
While retatrutide and SAR441255 demonstrate significant potential, several important aspects must be addressed to fully optimize the clinical application of triple agonists. Long-term studies are crucial to assess their safety and effectiveness across diverse patient populations. Exploring the mechanisms of...
Prescribing Information Important Safety Information | Patient Site For adults with type 2 diabetes as an adjunct to diet and exercise to improve glycemic control Wake up to RYBELSUS® (semaglutide)—the first type 2 diabetes pill in its class (GLP-1 RA)1 How...
Recent studies highlight potential risks to bone mineral density (BMD) and fracture risk, particularly in specific patient populations. Incorporating a regular exercise routine can help mitigate potential bone loss from GLP-1 drugs due to rapid weight loss.How Do GLP-1 Drugs Affect Bone Density?
SEE pg 2344 Figure 7-A (for slide data); pg 2335 “Study design” (for background information) DISCUSSION Mean rates of overall hypoglycaemia (episodes/patient-year (95% CI) were significantly less (p.05) in exenatide-treated patients compared with glargine-treated patients Sulphonylurea (SFU...